The FDA has released a drug safety advisory on the use of Sanofi's blood-thinning agent Lovenox in patients with spinal catheters. The FDA recommends that the placement or removal of catheters should be postponed for at least 12 hours after enoxaparin administration and 24 hours for patients receiving higher doses to reduce bleeding. The drug's warnings will be updated to include said recommendations.

Full Story:

Related Summaries